We are an Oxford, UK-based business with a revolutionary computer-based platform and a unique network-driven drug discovery ("NDD") methodology which allows us to discover novel and better drugs faster.

Who we are
Process overview.jpg
What we do

Read more about our cutting edge in silico techniques, the importance of network science, our strategy and our assets.

What we do
box-image-2.jpg
News and Media

View our regulatory announcements, read our publications, see our videos and subscribe to receive email alerts.

News & media
Amazon_450x450.png (1)
Investors

We are a UK-based company listed (ETX.L) on the Alternative Investment Market (AIM), London Stock Exchange's international market for smaller, growing companies.

Investors

Share price

6.75p

Share price information

Latest Report 2018

img-03.jpg 2018 Annual Report

Latest news

Research Collaboration Agreement with Novo Nordisk

Miscellaneous

Latest Regulatory Announcements

Partnering & Collaboration

Our NDD approach consistently generates potent and novel hits, assisting companies increase the productivity of their drug discovery.

Please get in touch at bd@etherapeutics.co.uk.